|
Liu, Ganqiang; Locascio, Joseph J; Corvol, Jean-Christophe et al. (2017) Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. Lancet Neurol 16:620-629
|
|
Liu, Ganqiang; Boot, Brendon; Locascio, Joseph J et al. (2016) Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. Ann Neurol 80:674-685
|
|
Locascio, Joseph J; Eberly, Shirley; Liao, Zhixiang et al. (2015) Association between ?-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease. Brain 138:2659-71
|
|
Tanner, Caroline M; Meng, Cheryl C; Ravina, Bernard et al. (2014) A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study. Mov Disord 29:743-9
|
|
Videnovic, Aleksandar; Noble, Charleston; Reid, Kathryn J et al. (2014) Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol 71:463-9
|
|
Lang, Anthony E; Eberly, Shirley; Goetz, Christopher G et al. (2013) Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments. Mov Disord 28:1980-6
|
|
Tsanas, Athanasios; Little, Max A; McSharry, Patrick E et al. (2012) Statistical analysis and mapping of the Unified Parkinson's Disease Rating Scale to Hoehn and Yahr staging. Parkinsonism Relat Disord 18:697-9
|
|
Ravina, Bernard; Marek, Kenneth; Eberly, Shirley et al. (2012) Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease. Mov Disord 27:1392-7
|
|
Saunders-Pullman, Rachel; Cabassa, Jose; San Luciano, Marta et al. (2011) LRRK2 G2019S mutations may be increased in Puerto Ricans. Mov Disord 26:1772-3
|
|
Brüggemann, Norbert; Hagenah, Johann; Stanley, Kaili et al. (2011) Substantia nigra hyperechogenicity with LRRK2 G2019S mutations. Mov Disord 26:885-8
|
Showing the most recent 10 out of 18 publications
